Catalyst Wire Dossier Catalyst Wire Dossier

SYR-322 25 mg

· Takeda
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYR-322 25 mg, covering 2016-06-06 to 2016-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy [Phase 3]

See pricing